OrthoAccel Secures $4,133,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    6575 West Loop South Bellaire, TX 77401
  • Company Description
    The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption. FDA will be reviewing the AcceleDent System, which is regulated as a medical device. If clearance is granted, the product will be available at an orthodontist near you.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    S3 Ventures

Trending on Xconomy

By posting a comment, you agree to our terms and conditions.

One response to “OrthoAccel Secures $4,133,000 New Funding”

  1. Bobl says:

    So instead, you leave it up to all the idealists and radicals to choose what the rest of society has to live with for 4 years, yep sounds really representative of the peoples (all the peoples) wishes to me . NOT. Even the lazy and uninformed have a right to be represented in a democracy.